ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 29 filers reported holding ATYR PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,590 | -37.7% | 236,449 | -14.9% | 0.00% | – |
| Q2 2023 | $600,056 | +93.4% | 277,804 | +88.0% | 0.00% | – |
| Q1 2023 | $310,323 | +71568.1% | 147,773 | -25.3% | 0.00% | – |
| Q4 2022 | $433 | -99.9% | 197,692 | +16.7% | 0.00% | – |
| Q3 2022 | $508,000 | +21.5% | 169,360 | +14.7% | 0.00% | – |
| Q2 2022 | $418,000 | -61.4% | 147,596 | -27.0% | 0.00% | – |
| Q1 2022 | $1,082,000 | -36.1% | 202,284 | -10.8% | 0.00% | -100.0% |
| Q4 2021 | $1,694,000 | -16.8% | 226,712 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $2,036,000 | +88.9% | 224,279 | +1.5% | 0.00% | – |
| Q2 2021 | $1,078,000 | +275.6% | 220,928 | +243.1% | 0.00% | – |
| Q1 2021 | $287,000 | +287.8% | 64,400 | +236.6% | 0.00% | – |
| Q4 2020 | $74,000 | +19.4% | 19,130 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -16.2% | 19,130 | +15.0% | 0.00% | – |
| Q2 2020 | $74,000 | -5.1% | 16,630 | -40.4% | 0.00% | – |
| Q1 2020 | $78,000 | – | 27,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |